Hildegard Büning

8.7k total citations · 1 hit paper
136 papers, 6.2k citations indexed

About

Hildegard Büning is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Hildegard Büning has authored 136 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 89 papers in Genetics and 29 papers in Oncology. Recurrent topics in Hildegard Büning's work include Virus-based gene therapy research (87 papers), RNA Interference and Gene Delivery (38 papers) and CRISPR and Genetic Engineering (33 papers). Hildegard Büning is often cited by papers focused on Virus-based gene therapy research (87 papers), RNA Interference and Gene Delivery (38 papers) and CRISPR and Genetic Engineering (33 papers). Hildegard Büning collaborates with scholars based in Germany, United States and France. Hildegard Büning's co-authors include Michael Hallek, Martin U. Ried, Luca Perabò, Axel Schambach, Christoph Bräuchle, Arun Srivastava, Michael Morgan, Christian J. Buchholz, Ulrich Hacker and Marianna Hösel and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Hildegard Büning

133 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-Time Single-Molecule Imaging of the Infection Pathway of an Adeno-Associated Virus

2001 652 citations Hildegard Büning, Michael Hallek et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hildegard Büning Germany	43	4.1k	3.2k	1.2k	831	735	136	6.2k
Boris Fehse Germany	54	5.1k 1.2×	2.8k 0.9×	2.7k 2.3×	1.5k 1.9×	603 0.8×	252	9.2k
Aravind Asokan United States	42	5.4k 1.3×	4.1k 1.3×	696 0.6×	240 0.3×	613 0.8×	137	7.1k
J. Fraser Wright United States	40	4.4k 1.1×	3.8k 1.2×	3.3k 2.8×	1.4k 1.7×	526 0.7×	89	7.9k
Jens Harborth Germany	16	8.7k 2.1×	1.5k 0.5×	624 0.5×	855 1.0×	384 0.5×	24	9.9k
David Pellman United States	70	14.1k 3.4×	2.6k 0.8×	2.9k 2.5×	761 0.9×	510 0.7×	113	19.0k
Mark A. Behlke United States	53	8.5k 2.1×	1.3k 0.4×	681 0.6×	2.0k 2.4×	595 0.8×	139	11.1k
D. Schultz United States	44	7.3k 1.8×	1.1k 0.3×	1.4k 1.2×	1.1k 1.3×	635 0.9×	119	9.9k
Douglas J. Jolly United States	37	3.3k 0.8×	2.5k 0.8×	857 0.7×	620 0.7×	672 0.9×	108	4.8k
W. French Anderson United States	56	7.3k 1.8×	5.2k 1.6×	2.2k 1.9×	1.5k 1.8×	908 1.2×	187	11.5k
Guido David Belgium	46	5.7k 1.4×	758 0.2×	550 0.5×	1.1k 1.3×	483 0.7×	100	8.8k

Countries citing papers authored by Hildegard Büning

Since Specialization

Citations

This map shows the geographic impact of Hildegard Büning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hildegard Büning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hildegard Büning more than expected).

Fields of papers citing papers by Hildegard Büning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hildegard Büning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hildegard Büning. The network helps show where Hildegard Büning may publish in the future.

Co-authorship network of co-authors of Hildegard Büning

This figure shows the co-authorship network connecting the top 25 collaborators of Hildegard Büning. A scholar is included among the top collaborators of Hildegard Büning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hildegard Büning. Hildegard Büning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sejersen, Thomas, Hildegard Büning, Michael Rothe, et al.. (2025). Pilocytic astrocytoma in a child with spinal muscular atrophy treated with onasemnogene abeparvovec. Molecular Therapy. 33(6). 2842–2850. 2 indexed citations

Schott, Juliane W., Peixin Huang, Michael Morgan, et al.. (2023). Third-generation lentiviral gene therapy rescues function in a mouse model of Usher 1B. Molecular Therapy. 31(12). 3502–3519. 10 indexed citations

Hardet, Romain, et al.. (2023). Capsid-modified adeno-associated virus vectors as novel vaccine platform for cancer immunotherapy. Molecular Therapy — Methods & Clinical Development. 29. 238–253. 8 indexed citations

Meumann, Nadja, Christian Schmithals, Tanja Hansen, et al.. (2022). Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors. Cancers. 14(2). 427–427. 7 indexed citations

Völkner, Manuela, Marina Pavlou, Hildegard Büning, Stylianos Michalakis, & Michael Karl. (2021). Optimized Adeno-Associated Virus Vectors for Efficient Transduction of Human Retinal Organoids. Human Gene Therapy. 32(13-14). 694–706. 26 indexed citations

Büning, Hildegard, Boris Fehse, Zoltán Ivics, et al.. (2021). Gene Therapy “Made in Germany”: A Historical Perspective, Analysis of the Status Quo, and Recommendations for Action by the German Society for Gene Therapy. Human Gene Therapy. 32(19-20). 987–996. 2 indexed citations

Hacker, Ulrich, et al.. (2021). Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses. Frontiers in Oncology. 11. 731598–731598. 32 indexed citations

Rossi, Axel, Nadja Meumann, Kathleen A. Christie, et al.. (2019). Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells. Human Gene Therapy. 30(10). 1284–1296. 22 indexed citations

Klapdor, Rüdiger, Shuo Wang, Ulrich Hacker, et al.. (2017). Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor–Based Immunotherapy and Chemotherapy. Human Gene Therapy. 28(10). 886–896. 81 indexed citations

10.

Ali, Robin R. & Hildegard Büning. (2017). Celebrating 25 Years of the European Society of Gene and Cell Therapy. Human Gene Therapy. 28(11). 939–939. 1 indexed citations

11.

Grimm, Dirk & Hildegard Büning. (2017). Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution. Human Gene Therapy. 28(11). 1075–1086. 93 indexed citations

12.

Nguyen, Xuan-Nhi, Grégory Berger, Andrea Cimarelli, et al.. (2015). Impact of the MRN Complex on Adeno-Associated Virus Integration and Replication during Coinfection with Herpes Simplex Virus 1. Journal of Virology. 89(13). 6824–6834. 12 indexed citations

13.

Münch, Robert C., Anke Muth, Alexander Muik, et al.. (2015). Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors. Nature Communications. 6(1). 6246–6246. 105 indexed citations

14.

Nicolas, Armel, Nathalie Alazard-Dany, Véronique Barateau, et al.. (2012). Factors influencing helper-independent adeno-associated virus replication. Virology. 432(1). 1–9. 7 indexed citations

15.

Büning, Hildegard. (2011). Gentherapie – Was ist das? “Heilen” mit Genen. Pharmazie in unserer Zeit. 40(3). 194–201. 1 indexed citations

16.

Hösel, Marianna, Maria Quasdorff, Katja Wiegmann, et al.. (2009). Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection†‡. Hepatology. 50(6). 1773–1782. 285 indexed citations

17.

Huber, Anke, et al.. (2009). Optimization of stealth adeno-associated virus vectors by randomization of immunogenic epitopes. Virology. 397(1). 167–175. 46 indexed citations

18.

Büning, Hildegard, et al.. (2008). Recent developments in adeno‐associated virus vector technology. The Journal of Gene Medicine. 10(7). 717–733. 129 indexed citations

19.

Hacker, Ulrich, David M. Kofler, Tobias Herold, et al.. (2005). Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency. The Journal of Gene Medicine. 7(11). 1429–1438. 51 indexed citations

20.

Büning, Hildegard, Markus Braun‐Falco, & Michael Hallek. (2004). Progress in the Use of Adeno-Associated Viral Vectors for Gene Therapy. Cells Tissues Organs. 177(3). 139–150. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact